Cingulate Inc. — Investor Relations & Filings
Filings indexed
448
across all filing types
Latest filing
2026-05-19
Regulatory Filings
Country
US
United States of America
Listing
US
CING
Cingulate Inc. is a clinical-stage biopharmaceutical company focused on developing treatments for Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety. The company utilizes its proprietary Precision Timed Release (PTR) drug delivery platform, a novel erosion-based technology, to create medications with a true once-daily dosing profile. This platform is designed to provide controlled drug release for entire active-day efficacy. Cingulate's pipeline includes product candidates CTX-1301 and CTX-1302 for the ADHD market, and CTX-2103 for the anxiety market.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K | 2026-05-19 | English | |
| 10-Q | 2026-05-14 | English | |
| 8-K | 2026-05-14 | English | |
| S-3 - Cingulate Inc. (0001862150) (Filer) | 2026-04-14 | English | |
| EFFECT - Cingulate Inc. (0001862150) (Filer) | 2026-03-27 | English | |
| SCHEDULE 13D/A - Cingulate Inc. (0001862150) (Subject) | 2026-03-26 | English |
Browse filings by year
6 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46558340 | 8-K | 2026-05-19 | English | ||
| 45998938 | 10-Q | 2026-05-14 | English | ||
| 45994080 | 8-K | 2026-05-14 | English | ||
| 34528394 | S-3 - Cingulate Inc. (0001862150) (Filer) | 2026-04-14 | English | ||
| 33057396 | EFFECT - Cingulate Inc. (0001862150) (Filer) | 2026-03-27 | English | ||
| 33052100 | SCHEDULE 13D/A - Cingulate Inc. (0001862150) (Subject) | 2026-03-26 | English | ||
| 33038981 | EFFECT - Cingulate Inc. (0001862150) (Filer) | 2026-03-25 | English | ||
| 33035416 | 8-K - Cingulate Inc. (0001862150) (Filer) | 2026-03-24 | English | ||
| 33035392 | 424B3 - Cingulate Inc. (0001862150) (Filer) | 2026-03-24 | English | ||
| 33013414 | S-3/A - Cingulate Inc. (0001862150) (Filer) | 2026-03-23 | English | ||
| 32974925 | 8-K - Cingulate Inc. (0001862150) (Filer) | 2026-03-18 | English | ||
| 32900022 | DEF 14A - CINGULATE INC. (0001862150) (Filer) | 2026-03-02 | English | ||
| 32111814 | 8-K Filing | 2026-02-17 | English | ||
| 32111863 | 4 Filing | 2026-02-10 | English | ||
| 32111808 | 4 Filing | 2026-02-10 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Krebs Biochemicals & Industries Ltd.
Develops and manufactures APIs and biotech products via fer…
|
KREBSBIO | IN | Manufacturing |
|
Kringle Pharma,Inc.
Develops HGF-based regenerative medicines for rare and intr…
|
4884 | JP | Manufacturing |
|
Krka
An international generic pharmaceutical company developing …
|
KRKG | SI | Manufacturing |
|
KRM Ayurveda Limited
Manufactures Ayurvedic and herbal healthcare products using…
|
KRMAYURVED | IN | Manufacturing |
|
Krystal Biotech, Inc.
Commercial-stage biotech developing genetic medicines for s…
|
KRYS | US | Manufacturing |
|
Kubota Pharmaceutical Holdings Co., Ltd.
A clinical-stage company developing drugs and devices for o…
|
4596 | JP | Manufacturing |
|
KUKJEON PHARMACEUTICAL Co.,Ltd
Develops and manufactures APIs and chemical materials for t…
|
307750 | KR | Manufacturing |
|
Kukje Pharma Co., Ltd.
Manufactures and distributes pharmaceuticals, cosmetics, an…
|
002720 | KR | Manufacturing |
|
Kuros Biosciences Ltd.
Develops biologic technologies for tissue repair and bone r…
|
KURN | CH | Manufacturing |
|
Kwality Pharmaceuticals Limited
Develops, manufactures, and exports diverse pharmaceutical …
|
KPL | IN | Manufacturing |
Cingulate Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/34936/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=34936 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=34936 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=34936 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 34936}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Cingulate Inc. (id: 34936)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.